Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
Botond Penke, Ferenc Bogár, Lívia Fülöp
Molecules (2017) Vol. 22, Iss. 10, pp. 1692-1692
Open Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer’s Disease—a Critical Review
Marta Sochocka, Katarzyna Donskow‐Łysoniewska, Breno S. Diniz, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 3, pp. 1841-1851
Open Access | Times Cited: 491
Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment
Ravinder Nagpal, Bryan J. Neth, Shaohua Wang, et al.
EBioMedicine (2019) Vol. 47, pp. 529-542
Open Access | Times Cited: 482
The Microbiota–Gut–Brain Axis and Alzheimer’s Disease: Neuroinflammation Is to Blame?
Ashwinipriyadarshini Megur, Daiva Baltriukienė, Virginija Bukelskienė, et al.
Nutrients (2020) Vol. 13, Iss. 1, pp. 37-37
Open Access | Times Cited: 227
The relationship between stress and Alzheimer's disease
Nicholas J. Justice
Neurobiology of Stress (2018) Vol. 8, pp. 127-133
Open Access | Times Cited: 199
Gut Microbiota in Alzheimer’s Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress
Maria Luca, M. Di Mauro, Marco Di Mauro, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-10
Open Access | Times Cited: 174
Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study
Ravinder Nagpal, Bryan J. Neth, Shaohua Wang, et al.
EBioMedicine (2020) Vol. 59, pp. 102950-102950
Open Access | Times Cited: 139
Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice
Yu Jiang, Kai Li, Xiaolin Li, et al.
Chemico-Biological Interactions (2021) Vol. 341, pp. 109452-109452
Closed Access | Times Cited: 104
Nanoformulations of Herbal Extracts in Treatment of Neurodegenerative Disorders
Seyed Zachariah Moradi, Saeideh Momtaz, Zahra Bayrami, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 136
Epigallocatechin‐3‐Gallate Attenuates Microglial Inflammation and Neurotoxicity by Suppressing the Activation of Canonical and Noncanonical Inflammasome via TLR4/NF‐κB Pathway
Xin Zhong, Mingyan Liu, Weifan Yao, et al.
Molecular Nutrition & Food Research (2019) Vol. 63, Iss. 21
Closed Access | Times Cited: 106
The Contribution of Gut Microbiota–Brain Axis in the Development of Brain Disorders
Jessica Maiuolo, Micaela Gliozzi, Vincenzo Musolino, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 102
Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors With Significant Neuroprotective Activity in SH-SY5Y Cells via Computational Molecular Modeling and in vitro Assay
Aimi Syamima Abdul Manap, Amelia Cheng Wei Tan, Weng Hhin Leong, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 88
Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer’s disease
Lauren A. Apodaca, Al Anoud D. Baddour, Camilo Garcia, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 72
New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer’s Disease
Botond Penke, Mária Szűcs, Ferenc Bogár
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5383-5383
Open Access | Times Cited: 23
CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease
Zdeněk Fišar, Jana Hroudová
Antioxidants (2024) Vol. 13, Iss. 2, pp. 191-191
Open Access | Times Cited: 11
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
Devika Jadhav, Nikita Saraswat, Neeraj S. Vyawahare, et al.
The Egyptian Journal of Neurology Psychiatry and Neurosurgery (2024) Vol. 60, Iss. 1
Open Access | Times Cited: 8
Ca2+homeostasis dysregulation in Alzheimer's disease: a focus on plasma membrane and cell organelles
Xingjian Wang, Wei Zheng
The FASEB Journal (2019) Vol. 33, Iss. 6, pp. 6697-6712
Open Access | Times Cited: 75
Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration
Sonali Nashine, Pinchas Cohen, Anthony B. Nesburn, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 60
“Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease
Chinthalapally V. Rao, Adam S. Asch, Daniel J.J. Carr, et al.
Aging Cell (2020) Vol. 19, Iss. 3
Open Access | Times Cited: 55
Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer’s disease pathogenesis
Filippo Sean Giorgi, Alessandro Galgani, Stefano Puglisi‐Allegra, et al.
Journal of Neuroscience Research (2020) Vol. 98, Iss. 12, pp. 2406-2434
Closed Access | Times Cited: 52
Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer’s Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress
Yubin Liang, Cheng-Hui Ye, Yuling Chen, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 11, pp. 1894-1904
Closed Access | Times Cited: 50
The critical role of gut-brain axis microbiome in mental disorders
Kimia Basiji, Azadeh Aghamohammadi Sendani, Shaghayegh Baradaran Ghavami, et al.
Metabolic Brain Disease (2023) Vol. 38, Iss. 8, pp. 2547-2561
Closed Access | Times Cited: 17
A Cross-Sectional Study of Alzheimer-Related Proteins in Women with Polycystic Ovary Syndrome
Alexandra E. Butler, Abu Saleh Md Moin, Thozhukat Sathyapalan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1158-1158
Open Access | Times Cited: 6
Role of mtDNA disturbances in the pathogenesis of Alzheimer’s and Parkinson’s disease
Veronika Antonyová, Zdeněk Kejík, Tereza Brogyányi, et al.
DNA repair (2020) Vol. 91-92, pp. 102871-102871
Closed Access | Times Cited: 41
CircAXL Knockdown Alleviates Aβ1-42-Induced Neurotoxicity in Alzheimer’s Disease via Repressing PDE4A by Releasing miR-1306-5p
Shengxi Meng, Bing Wang, Wentao Li
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1707-1720
Open Access | Times Cited: 27
Natural Products as the Potential to Improve Alzheimer’s and Parkinson’s Disease
Sung Wook Kim, Jun Ho Lee, Bumjung Kim, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8827-8827
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top